TEXT-EXTRACT 2 filename2.txt United States securities and exchange commission logo December 5, 2023 Don Kim Chief Financial Officer UroGen Pharma Ltd. 400 Alexander Park Princeton, NJ 08540 Re: UroGen Pharma Ltd. Form 10-K for Fiscal Year Ended December 31, 2022 File No. 001-38079 Dear Don Kim: We have completed our review of your filings. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Sincerely, Division of Corporation Finance Office of Life Sciences